Tumor regression grading
Showing 1 - 25 of >10,000
Predict Tumor Regression Grading in Locally Advanced Rectal
Unknown status
- Rectal Cancer
-
Guangzhou, Guangdong, China
- +2 more
Feb 15, 2020
MRI-based Computer Aided Diagnosis Software (V1) for Glioma
Enrolling by invitation
- Glioma
- Primary Brain Tumor
-
Shanghai, Shanghai, ChinaZhen Fan
Feb 11, 2023
Oncological Impact of Lateral Nodes in Rectal Cancer
Completed
- Colorectal Adenocarcinoma
- Neoadjuvant chemoradiotherapy (CRT)
- (no location specified)
Oct 20, 2022
DLCS for Predicting Neoadjuvant Chemotherapy Response
Recruiting
- Gastric Cancer
- +4 more
- develop and visualized a radio-clinical signatures from pretreatment oversampled CT images
-
Hangzhou, Zhejiang, ChinaCancer Hospital of the University of Chinese Academy of Sciences
Nov 8, 2022
Potential Benefit of Neoadjuvant Therapy for AGC Patients
Not yet recruiting
- Early Gastric Cancer
- Tumor Organoids
- (no location specified)
Jul 26, 2022
Gastric Cancer, Adenocarcinoma of the Stomach Trial in Roma (CT scan)
Recruiting
- Gastric Cancer
- Adenocarcinoma of the Stomach
- CT scan
-
Roma, ItalyGiovanni Maria Garbarino
May 6, 2021
Colorectal Tumors Trial in New York (Botensilimab, Balstilimab)
Not yet recruiting
- Colorectal Neoplasms
-
New York, New YorkWeill Cornell Medicine/NewYork-Presbyterian Hospital
Jan 24, 2023
Colorectal Cancer Trial (Ezabenlimab, BI 765063, Pembrolizumab)
Recruiting
- Colorectal Cancer
- Ezabenlimab
- +2 more
-
New York, New YorkMount Sinai School of Medicine
Jan 10, 2023
Rectal Cancer Trial (CapeOX + cetuximab, CapeOX + bevacizumab, radiotherapy)
Not yet recruiting
- Rectal Cancer
- CapeOX + cetuximab
- +2 more
- (no location specified)
Sep 12, 2023
Rectum Adenocarcinoma Trial in Paris, Saint-Cloud (Biopsy)
Recruiting
- Rectum Adenocarcinoma
- Biopsy
-
Paris, Ile De France, France
- +2 more
Mar 30, 2022
Oligometastatic Gastric Adenocarcinoma Trial in Verona (FOLFOX and PIPAC)
Recruiting
- Oligometastatic Gastric Adenocarcinoma
- FOLFOX and PIPAC
-
Verona, ItalyAOUI Verona
Jul 19, 2022
Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)
Recruiting
- Rectal Cancer
- Kineret 100 MG in 0.67 ML Prefilled Syringe
- +3 more
-
Frankfurt, GermanyUniversity Hospital Goethe University Frankfurt
Aug 23, 2022
Timisnar - Biomarkers Substudy (Timisnar-mirna)
Recruiting
- Rectal Cancer
- miRNA
-
Alessandria, ItalySS. Antonio e Biagio e Cesare Arrigo
Jul 27, 2021
Pancreatic Cancer Trial in Baltimore (Tislelizumab, SX-682)
Not yet recruiting
- Pancreatic Cancer
-
Baltimore, MarylandJohns Hopkins SKCCC
Jan 23, 2023
Hepatic Steatosis in MAFLD With UDFF
Not yet recruiting
- Fatty Liver Disease, Nonalcoholic
- bariatric surgery (BS)
- (no location specified)
Oct 18, 2023
Glioma Grading and Genotyping
Recruiting
- Glioma
-
Chongqing, Chongqing, ChinaSang Zifan
Aug 29, 2023
Axillary Nodal Status After Neoadjuvant Chemotherapy in Breast
Active, not recruiting
- Breast Cancer
-
Pavia, Lombardia, ItalyIstituti Clinici Scientifici Maugeri SpA
Mar 22, 2023
Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage II Gastroesophageal Junction
Not yet recruiting
- Clinical Stage I Gastric Cancer AJCC v8
- +9 more
- Atezolizumab
- +12 more
- (no location specified)
Apr 26, 2023
Clinical Stage IV Gastric Cancer AJCC v8, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Rochester
Not yet recruiting
- Clinical Stage IV Gastric Cancer AJCC v8
- +4 more
- Aldesleukin
- +10 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 5, 2023
Neoadjuvant Therapy Trial (standard long-term therapy, FOLFOX and standard long-term radiotherapy, FOLFIRI and standard
Not yet recruiting
- Neoadjuvant Therapy
- standard long-term therapy
- +5 more
- (no location specified)
Apr 22, 2022
Recurrent Neuroblastoma, Recurrent Osteosarcoma, Refractory Neuroblastoma Trial in Bethesda, Seattle, Madison (Cyclophosphamide,
Recruiting
- Recurrent Neuroblastoma
- +3 more
- Cyclophosphamide
- +2 more
-
Palo Alto, California
- +3 more
Jan 25, 2023
Esophageal Squamous Cell Carcinoma Stage II, Esophageal Squamous Cell Carcinoma Stage III Trial in Shanghai (Neoadjuvant
Recruiting
- Esophageal Squamous Cell Carcinoma Stage II
- Esophageal Squamous Cell Carcinoma Stage III
- Neoadjuvant Chemoradiotherapy
- +2 more
-
Shanghai, ChinaShanghai Zhongshan Hospital
Jun 26, 2022
Rectal Cancer, Rectal Cancer Stage II, Rectal Cancer Stage III Trial in Guangzhou (drug, radiation, procedure, other)
Recruiting
- Rectal Cancer
- +3 more
- Capecitabine, Oxaliplatin
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 19, 2022